IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21 | +50.0% | 9,600 | +357.1% | 0.00% | 0.0% |
Q2 2023 | $14 | +16.7% | 2,100 | 0.0% | 0.00% | +100.0% |
Q1 2023 | $12 | -63.6% | 2,100 | -77.3% | 0.00% | -66.7% |
Q4 2022 | $33 | -99.9% | 9,231 | -63.5% | 0.00% | +200.0% |
Q3 2022 | $27,000 | -53.4% | 25,300 | -7.0% | 0.00% | -75.0% |
Q2 2022 | $58,000 | -72.4% | 27,200 | -75.7% | 0.00% | -63.6% |
Q1 2022 | $210,000 | -56.2% | 112,014 | +87.6% | 0.01% | -45.0% |
Q4 2021 | $480,000 | -58.0% | 59,703 | -60.3% | 0.02% | -60.8% |
Q3 2021 | $1,142,000 | +89.7% | 150,226 | +42.4% | 0.05% | +82.1% |
Q2 2021 | $602,000 | +4530.8% | 105,493 | +282.2% | 0.03% | +2700.0% |
Q1 2021 | $13,000 | -92.0% | 27,600 | -24.0% | 0.00% | -87.5% |
Q4 2020 | $163,000 | -39.6% | 36,300 | +179.0% | 0.01% | -52.9% |
Q3 2020 | $270,000 | +938.5% | 13,009 | -68.8% | 0.02% | +750.0% |
Q2 2020 | $26,000 | -86.2% | 41,700 | -17.6% | 0.00% | -80.0% |
Q1 2020 | $189,000 | +177.9% | 50,600 | +411.1% | 0.01% | +150.0% |
Q4 2019 | $68,000 | +1033.3% | 9,900 | -33.6% | 0.00% | +300.0% |
Q3 2019 | $6,000 | -53.8% | 14,900 | +186.5% | 0.00% | 0.0% |
Q2 2019 | $13,000 | -78.3% | 5,200 | -65.3% | 0.00% | -75.0% |
Q3 2018 | $60,000 | +39.5% | 15,000 | -1.9% | 0.00% | 0.0% |
Q1 2018 | $43,000 | +186.7% | 15,296 | -12.1% | 0.00% | – |
Q4 2017 | $15,000 | +66.7% | 17,400 | +295.5% | 0.00% | – |
Q3 2017 | $9,000 | -82.0% | 4,400 | -86.8% | 0.00% | -100.0% |
Q2 2017 | $50,000 | – | 33,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |